Effect of clozapine on serum leptin, insulin levels, and body weight and composition in patients with schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 27, Issue 5, 2003, Pages 795-799

  Kivircik, Berna Binnur ^a,d   Alptekin, Köksal ^a   Çalişkan, Sezer ^a   Çömlekçi, Abdurrahman ^a   Örük, Gonca ^a   Tümüklü, Mevhibe ^a   Kürklü, Kablan ^a   Arkar, Haluk ^a   Türk, Ayşe ^b   Çalişkan, Mehmet ^c   Yeşil, Sena ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b ADNAN MENDERES UNIVERSITY   (Turkey)

^c Izmir Atatürk State Hospital   (Turkey)

^d NONE   (Turkey)

Author keywords

Body composition; Clozapine; Leptin; Schizophrenia; Weight gain

Indexed keywords

CLOZAPINE; INSULIN; LEPTIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CORRELATION ANALYSIS; DOSE RESPONSE; FEMALE; HUMAN; INSULIN BLOOD LEVEL; LEAN BODY WEIGHT; MALE; MUSCLE MASS; PROTEIN BLOOD LEVEL; RATING SCALE; SCHIZOPHRENIA; SIDE EFFECT; TOTAL BODY WATER; WEIGHT GAIN;

EID: 0042131950     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(03)00111-8     Document Type: Article

References (22)

1. Allison D.B., Mentore J.L., Heo M., Chandler L.P., Cappelleri J.C., Infante M.C., Weiden P.J. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am. J. Psychiatry. 156:1999;1686-1696.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th ed. 1994;American Psychiatric Association, Washington, DC.
3. Baptista T., Alvarez L., Lacruz A., Mendoza S.D., Hernandez L. Glucose tolerance and serum insulin levels in an animal model of obesity induced by sub-acute or chronic administration of antipsychotic drugs. Prog. Neuro-psychopharmacol. Biol. Psychiatry. 23:1999;277-287.
4. Bromel T., Blum W.F., Ziegler A., Schulz E., Bender M., Flesichhaker C., Remschmidt H., Krieg J.C., Hebebrand J. Serum leptin levels increase rapidly after initiation of clozapine therapy. Mol. Psychiatry. 3:1998;76-80.
5. Bustillo J.R., Buchanan R.W., Irish D., Breier A. Differential effect of clozapine on weight: a controlled study. Am. J. Psychiatry. 153:1996;817-819.
6. Compastona A., Grillo G., Bessarione D., De Grandi R., Adami G.F. Relationships of serum leptin to body composition and resting energy expenditure. Horm. Metab. Res. 30(10):1998;646-647.
7. Henderson D.C., Cagliero E., Gray C., Nasrallah R.A., Hayden D.L., Schoenfeld D.A., Goff D.C. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study. Am. J. Psychiatry. 157:2000;975-981.
8. Herran A., Garcia-Unzueta M.T., Amado J.A., De La Maza M.T., Alvarez C., Vazquez-Barquero J.L. Effects of long-term treatment with antipsychotics on serum leptin levels. Br. J. Psychiatry. 179:2001;59-62.
9. Kane J., Honigfeld G., Singer J., Meltzer H. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch. Gen. Psychiatry. 45:1988;789-796.
10. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 13(2):1987;261-276.
11. Kolanczyniski J.W., Nyce M.R., Considine R.V., Boden G., Nolan J.J., Henry R., Mudaliar S.R., Olefsky J., Caro J.F. Acute and chronic effect of insulin on leptin production in humans. Diabetes. 45:1996;988-991.
12. Kraus T., Haack M., Schuld A., Dunja H.S., Kühn M., Uhr M., Pollmacher T. Body weight and leptin plasma levels during treatment with antipsychotic drugs. Am. J. Psychiatry. 156:1999;312-314.
13. Lamberti J.S., Bellnier T., Schwarzkopf S.B. Weight gain among schizophrenic patients treated with clozapine. Am. J. Psychiatry. 149:1992;689-690.
14. Leadbetter R., Shutty M., Pavalonis D., Viewig V., Higgins P., Downs M. Clozapine induced weight-gain: prevelance and clinical relevance. Am. J. Psychiatry. 149:1992;68-72.
15. Martin L.J., Jones P.J., Considine R.V., Su W., Boyd N.F., Caro J.F. Serum leptin levels and energy expenditure in normal weight women. Can. J. Physiol. Pharm. 76(2):1998;237-241.
16. Melkersson K.I., Hulting A.L. Insulin and leptin levels in patients with schizophrenia or related psychoses: a comparison between antipsychotic agents. Psychopharmacology. 154(2):2001;205-212.
17. Melkersson K., Khan A., Hilding A., Hulting A.L. Different effects of antipsychotic drugs on insulin release in vitro. Eur. Neuropsychopharmacol. 11:2001;327-332.
18. Meltzer H.Y. Suicide in schizophrenia: risk factors and clozapine treatment. J. Clin. Psychiatry. 59(Suppl. 3):1998;3-7.
19. Meltzer H.Y., Perry E., Jayathilake K. Clozapine-induced weight gain predicts improvement in psychopathology. Schizophrenia Res. 59(1):2003;19-27.
20. Monteleone P., Fabrazzo M., Tortorella A., La Pia S., Maj M. Pronounced early increase in circulating leptin predicts a lower weight gain during clozapine treatment. J. Clin. Psychopharmacol. 22(4):2002;424-426.
21. Umbricht D.S.G., Pollack S., Kane J.M. Clozapine and weight gain. J. Clin. Psychiatry. 55(Suppl. B):1994;157-160.
22. Woods S.C., Kaiyala K., Porte D., Schwartz M.W. Food intake and energy balance. Porte D., Sherwin R.S. Diabetes Mellitus. 1997;175-192 Appleton and Lange Stamford, Connecticut.